BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang S, Li X, Yang F, Zhao R, Pan X, Liang J, Tian L, Li X, Liu L, Xing Y, Wu M. Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target. Front Pharmacol 2019;10:1360. [PMID: 31803054 DOI: 10.3389/fphar.2019.01360] [Cited by in Crossref: 48] [Cited by in F6Publishing: 96] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Jia B, Zou Y, Han X, Bae JW, Jeon CO. Gut microbiome-mediated mechanisms for reducing cholesterol levels: implications for ameliorating cardiovascular disease. Trends Microbiol 2022:S0966-842X(22)00215-3. [PMID: 36008191 DOI: 10.1016/j.tim.2022.08.003] [Reference Citation Analysis]
2 Cuinat C, Stinson SE, Ward WE, Comelli EM. Maternal Intake of Probiotics to Program Offspring Health. Curr Nutr Rep. [DOI: 10.1007/s13668-022-00429-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang Z, You L, Ren Y, Zhu X, Mao X, Liang X, Wang T, Guo Y, Liu T, Xue J. Finasteride Alleviates High Fat Associated Protein-Overload Nephropathy by Inhibiting Trimethylamine N-Oxide Synthesis and Regulating Gut Microbiota. Front Physiol 2022;13:900961. [DOI: 10.3389/fphys.2022.900961] [Reference Citation Analysis]
4 Bilal M, Ashraf S, Zhao X. Dietary Component-Induced Inflammation and Its Amelioration by Prebiotics, Probiotics, and Synbiotics. Front Nutr 2022;9:931458. [DOI: 10.3389/fnut.2022.931458] [Reference Citation Analysis]
5 Cao Y, Aquino-Martinez R, Hutchison E, Allayee H, Lusis AJ, Rey FE. Role of gut microbe-derived metabolites in cardiometabolic diseases: Systems based approach. Mol Metab 2022;:101557. [PMID: 35870705 DOI: 10.1016/j.molmet.2022.101557] [Reference Citation Analysis]
6 Feng W, Liu J, Cheng H, Zhang D, Tan Y, Peng C. Dietary compounds in modulation of gut microbiota-derived metabolites. Front Nutr 2022;9:939571. [DOI: 10.3389/fnut.2022.939571] [Reference Citation Analysis]
7 Varela-trinidad GU, Domínguez-díaz C, Solórzano-castanedo K, Íñiguez-gutiérrez L, Hernández-flores TDJ, Fafutis-morris M. Probiotics: Protecting Our Health from the Gut. Microorganisms 2022;10:1428. [DOI: 10.3390/microorganisms10071428] [Reference Citation Analysis]
8 Liu J, Tan Y, Cheng H, Zhang D, Feng W, Peng C. Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives. Aging Dis 2022;13:1106-26. [PMID: 35855347 DOI: 10.14336/AD.2022.0104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
9 Qiao J, Liang Y, Wang Y, Morigen. Trimethylamine N-Oxide Reduces the Susceptibility of Escherichia coli to Multiple Antibiotics. Front Microbiol 2022;13:956673. [DOI: 10.3389/fmicb.2022.956673] [Reference Citation Analysis]
10 Wang J, Zhang J, Ye Y, Xu Q, Li Y, Feng S, Xiong X, Jian Z, Gu L. Peripheral Organ Injury After Stroke. Front Immunol 2022;13:901209. [PMID: 35720359 DOI: 10.3389/fimmu.2022.901209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Chen CY, Leu HB, Wang SC, Tsai SH, Chou RH, Lu YW, Tsai YL, Kuo CS, Huang PH, Chen JW, Lin SJ. Inhibition of Trimethylamine N-oxide attenuates neointimal formation through reduction of inflammasome and oxidative stress in a mouse model of carotid artery ligation. Antioxid Redox Signal 2022. [PMID: 35713239 DOI: 10.1089/ars.2021.0115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang Z, Li F, Liu J, Luo Y, Guo H, Yang Q, Xu C, Ma S, Chen H. Intestinal Microbiota - An Unmissable Bridge to Severe Acute Pancreatitis-Associated Acute Lung Injury. Front Immunol 2022;13:913178. [DOI: 10.3389/fimmu.2022.913178] [Reference Citation Analysis]
13 Valenzuela-Vallejo L, Chrysafi P, Bello-Ramos J, Bsata S, Mantzoros CS. Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide or lorcaserin treatment in humans with obesity. Metabolism 2022;133:155237. [PMID: 35700837 DOI: 10.1016/j.metabol.2022.155237] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Coutinho-Wolino KS, da Cruz BO, Cardozo LFMF, Fernandes IA, Mesquita CT, Stenvinkel P, Bergman P, Mafra D, Stockler-Pinto MB. Brazil nut supplementation does not affect trimethylamine-n-oxide plasma levels in patients with coronary artery disease. J Food Biochem 2022;:e14201. [PMID: 35467017 DOI: 10.1111/jfbc.14201] [Reference Citation Analysis]
15 Li C, Liang Y, Qiao Y. Messengers From the Gut: Gut Microbiota-Derived Metabolites on Host Regulation. Front Microbiol 2022;13:863407. [DOI: 10.3389/fmicb.2022.863407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Zhang X, Gérard P. Diet-gut microbiota interactions on cardiovascular disease. Comput Struct Biotechnol J 2022;20:1528-40. [PMID: 35422966 DOI: 10.1016/j.csbj.2022.03.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Chidambaram SB, Rathipriya AG, Mahalakshmi AM, Sharma S, Hediyal TA, Ray B, Sunanda T, Rungratanawanich W, Kashyap RS, Qoronfleh MW, Essa MM, Song BJ, Monaghan TM. The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke. Cells 2022;11:1239. [PMID: 35406804 DOI: 10.3390/cells11071239] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Liu G, Cheng J, Zhang T, Shao Y, Chen X, Han L, Zhou R, Wu B. Inhibition of Microbiota-dependent Trimethylamine N-Oxide Production Ameliorates High Salt Diet-Induced Sympathetic Excitation and Hypertension in Rats by Attenuating Central Neuroinflammation and Oxidative Stress. Front Pharmacol 2022;13:856914. [PMID: 35359866 DOI: 10.3389/fphar.2022.856914] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Qu L, Cheng Q, Wang Y, Mu H, Zhang Y. COPD and Gut–Lung Axis: How Microbiota and Host Inflammasome Influence COPD and Related Therapeutics. Front Microbiol 2022;13:868086. [DOI: 10.3389/fmicb.2022.868086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Xu M, Lv C, Wang H, Lu Q, Ye M, Zhu X, Liu R. Peanut skin extract ameliorates high-fat diet-induced atherosclerosis by regulating lipid metabolism, inflammation reaction and gut microbiota in ApoE−/− mice. Food Research International 2022;154:111014. [DOI: 10.1016/j.foodres.2022.111014] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Barcena ML, Aslam M, Pozdniakova S, Norman K, Ladilov Y. Cardiovascular Inflammaging: Mechanisms and Translational Aspects. Cells 2022;11:1010. [DOI: 10.3390/cells11061010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Castiglione Morelli MA, Iuliano A, Schettini SCA, Ferri A, Colucci P, Viggiani L, Matera I, Ostuni A. Are the Follicular Fluid Characteristics of Recovered Coronavirus Disease 2019 Patients Different From Those of Vaccinated Women Approaching in vitro Fertilization? Front Physiol 2022;13:840109. [PMID: 35283772 DOI: 10.3389/fphys.2022.840109] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Chen S, Rong X, Sun X, Zou Y, Zhao C, Wang H. A Novel Trimethylamine Oxide-Induced Model Implicates Gut Microbiota-Related Mechanisms in Frailty. Front Cell Infect Microbiol 2022;12:803082. [DOI: 10.3389/fcimb.2022.803082] [Reference Citation Analysis]
24 Grosso G, Laudisio D, Frias-Toral E, Barrea L, Muscogiuri G, Savastano S, Colao A. Anti-Inflammatory Nutrients and Obesity-Associated Metabolic-Inflammation: State of the Art and Future Direction. Nutrients 2022;14:1137. [PMID: 35334794 DOI: 10.3390/nu14061137] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
25 Gebrayel P, Nicco C, Al Khodor S, Bilinski J, Caselli E, Comelli EM, Egert M, Giaroni C, Karpinski TM, Loniewski I, Mulak A, Reygner J, Samczuk P, Serino M, Sikora M, Terranegra A, Ufnal M, Villeger R, Pichon C, Konturek P, Edeas M. Microbiota medicine: towards clinical revolution. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03296-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
26 Korf JM, Ganesh BP, Mccullough LD. Gut dysbiosis and age-related neurological diseases in females. Neurobiology of Disease 2022;168:105695. [DOI: 10.1016/j.nbd.2022.105695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
27 Amrein M, Li XS, Walter J, Wang Z, Zimmermann T, Strebel I, Honegger U, Leu K, Schäfer I, Twerenbold R, Puelacher C, Glarner N, Nestelberger T, Koechlin L, Ceresa B, Haaf P, Bakula A, Zellweger M, Hazen SL, Mueller C. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD). Clin Res Cardiol. [DOI: 10.1007/s00392-022-01992-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
28 Liu J, Hefni ME, Witthöft CM, Bergström M, Burleigh S, Nyman M, Hållenius F. Effects of Whole Brown Bean and Its Isolated Fiber Fraction on Plasma Lipid Profile, Atherosclerosis, Gut Microbiota, and Microbiota-Dependent Metabolites in Apoe-/- Mice. Nutrients 2022;14:937. [PMID: 35267913 DOI: 10.3390/nu14050937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Wang Y, He B, Liu K, Shi J, Li A, Cheng J, Wei Y, Guo S, Wang Y, Ding B. Effects of long-term dietary supplementation of fermented wheat bran on immune performance and inflammatory response in laying hens. Food and Agricultural Immunology 2022;33:150-66. [DOI: 10.1080/09540105.2021.2025346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Li X, Fan Z, Cui J, Li D, Lu J, Cui X, Xie L, Wu Y, Lin Q, Li Y. Trimethylamine N-Oxide in Heart Failure: A Meta-Analysis of Prognostic Value. Front Cardiovasc Med 2022;9:817396. [DOI: 10.3389/fcvm.2022.817396] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Xiang H, Sun D, Liu X, She Z, Chen Y. The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis. Front Endocrinol 2022;13:812610. [DOI: 10.3389/fendo.2022.812610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Awad A, Madla CM, McCoubrey LE, Ferraro F, Gavins FKH, Buanz A, Gaisford S, Orlu M, Siepmann F, Siepmann J, Basit AW. Clinical translation of advanced colonic drug delivery technologies. Adv Drug Deliv Rev 2022;181:114076. [PMID: 34890739 DOI: 10.1016/j.addr.2021.114076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 8.0] [Reference Citation Analysis]
33 Zizmare L, Boyle CN, Buss S, Louis S, Kuebler L, Mulay K, Krüger R, Steinhauer L, Mack I, Rodriguez Gomez M, Herfert K, Ritze Y, Trautwein C. Roux-En-Y Gastric Bypass (RYGB) Surgery during High Liquid Sucrose Diet Leads to Gut Microbiota-Related Systematic Alterations. Int J Mol Sci 2022;23:1126. [PMID: 35163046 DOI: 10.3390/ijms23031126] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Li Y, Kang J, Lee Y, Chung JY, Cho JY. A validated simple LC-MS/MS method for quantifying trimethylamine N-oxide (TMAO) using a surrogate matrix and its clinical application. Transl Clin Pharmacol 2021;29:216-25. [PMID: 35024362 DOI: 10.12793/tcp.2021.29.e19] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Lombardo M, Aulisa G, Marcon D, Rizzo G. The Influence of Animal- or Plant-Based Diets on Blood and Urine Trimethylamine-N-Oxide (TMAO) Levels in Humans. Curr Nutr Rep 2022. [PMID: 34990005 DOI: 10.1007/s13668-021-00387-9] [Reference Citation Analysis]
36 Gold A, Zhu J. Not just a gut feeling: a deep exploration of functional bacterial metabolites that can modulate host health. Gut Microbes 2022;14:2125734. [PMID: 36127825 DOI: 10.1080/19490976.2022.2125734] [Reference Citation Analysis]
37 Ji C, Li Y, Mo Y, Lu Z, Lu F, Lin Q, Liu X, Zou C, Wu Y. Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats. Front Pharmacol 2021;12:780924. [PMID: 34966280 DOI: 10.3389/fphar.2021.780924] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
38 Filosa A, Sawamiphak S. Heart development and regeneration-a multi-organ effort. FEBS J 2021. [PMID: 34894086 DOI: 10.1111/febs.16319] [Reference Citation Analysis]
39 Huang R, Yan L, Lei Y. The Gut Microbial-Derived Metabolite Trimethylamine N-Oxide and Atrial Fibrillation: Relationships, Mechanisms, and Therapeutic Strategies. Clin Interv Aging 2021;16:1975-86. [PMID: 34876810 DOI: 10.2147/CIA.S339590] [Reference Citation Analysis]
40 Chen J, Qin Q, Yan S, Yang Y, Yan H, Li T, Wang L, Gao X, Li A, Ding S. Gut Microbiome Alterations in Patients With Carotid Atherosclerosis. Front Cardiovasc Med 2021;8:739093. [PMID: 34869642 DOI: 10.3389/fcvm.2021.739093] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Sawicka-Śmiarowska E, Moniuszko-Malinowska A, Kamiński KA. Which Microbes Like My Diet and What Does It Mean for My Heart? Nutrients 2021;13:4146. [PMID: 34836400 DOI: 10.3390/nu13114146] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Hu X, Fan Y, Li H, Zhou R, Zhao X, Sun Y, Zhang S. Impacts of Cigarette Smoking Status on Metabolomic and Gut Microbiota Profile in Male Patients With Coronary Artery Disease: A Multi-Omics Study. Front Cardiovasc Med 2021;8:766739. [PMID: 34778417 DOI: 10.3389/fcvm.2021.766739] [Reference Citation Analysis]
43 Potrykus M, Czaja-Stolc S, Stankiewicz M, Kaska Ł, Małgorzewicz S. Intestinal Microbiota as a Contributor to Chronic Inflammation and Its Potential Modifications. Nutrients 2021;13:3839. [PMID: 34836095 DOI: 10.3390/nu13113839] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
44 Bergström H, Lindahl A, Warnqvist A, Diczfalusy U, Ekström L, Björkhem-Bergman L. Studies on CYP3A activity during the menstrual cycle as measured by urinary 6β-hydroxycortisol/cortisol. Pharmacol Res Perspect 2021;9:e00884. [PMID: 34664787 DOI: 10.1002/prp2.884] [Reference Citation Analysis]
45 Mertowska P, Mertowski S, Wojnicka J, Korona-Głowniak I, Grywalska E, Błażewicz A, Załuska W. A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects. Nutrients 2021;13:3637. [PMID: 34684638 DOI: 10.3390/nu13103637] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
46 Morton KR, Lee JW, Spencer-Hwang R. Plant-based dietary intake moderates adverse childhood experiences association with early mortality in an older Adventist cohort. J Psychosom Res 2021;151:110633. [PMID: 34634675 DOI: 10.1016/j.jpsychores.2021.110633] [Reference Citation Analysis]
47 Alhajri N, Khursheed R, Ali MT, Abu Izneid T, Al-Kabbani O, Al-Haidar MB, Al-Hemeiri F, Alhashmi M, Pottoo FH. Cardiovascular Health and The Intestinal Microbial Ecosystem: The Impact of Cardiovascular Therapies on The Gut Microbiota. Microorganisms 2021;9:2013. [PMID: 34683334 DOI: 10.3390/microorganisms9102013] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
48 Pena MJ, Costa R, Rodrigues I, Martins S, Guimarães JT, Faria A, Calhau C, Rocha JC, Borges N. Unveiling the Metabolic Effects of Glycomacropeptide. Int J Mol Sci 2021;22:9731. [PMID: 34575895 DOI: 10.3390/ijms22189731] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Shen X, Li L, Sun Z, Zang G, Zhang L, Shao C, Wang Z. Gut Microbiota and Atherosclerosis-Focusing on the Plaque Stability. Front Cardiovasc Med 2021;8:668532. [PMID: 34414217 DOI: 10.3389/fcvm.2021.668532] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
50 Tascanov MB, Tanriverdi Z, Gungoren F, Besli F, Erkus ME, Koyuncu I, Gonel A, Genc Tapar G. Comparisons of microbiota-generated metabolites in patients with young and elderly acute coronary syndrome. Anatol J Cardiol 2020;24:175-82. [PMID: 32870170 DOI: 10.14744/AnatolJCardiol.2020.47995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Pietrzyk-Brzezinska AJ, Cociurovscaia A. Structures of the TetR-like transcription regulator RcdA alone and in complexes with ligands. Proteins 2022;90:33-44. [PMID: 34288132 DOI: 10.1002/prot.26183] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
52 Yang S, Li D, Yu Z, Li Y, Wu M. Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota. Front Pharmacol 2021;12:709629. [PMID: 34305616 DOI: 10.3389/fphar.2021.709629] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
53 Zhong X, Zhang F, Yin X, Cao H, Wang X, Liu D, Chen J, Chen X. Bone Homeostasis and Gut Microbial-Dependent Signaling Pathways. J Microbiol Biotechnol 2021;31:765-74. [PMID: 34176870 DOI: 10.4014/jmb.2104.04016] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
54 Fang Q, Zheng B, Liu N, Liu J, Liu W, Huang X, Zeng X, Chen L, Li Z, Ouyang D. Trimethylamine N-Oxide Exacerbates Renal Inflammation and Fibrosis in Rats With Diabetic Kidney Disease. Front Physiol 2021;12:682482. [PMID: 34220546 DOI: 10.3389/fphys.2021.682482] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
55 He S, Jiang H, Zhuo C, Jiang W. Trimethylamine/Trimethylamine-N-Oxide as a Key Between Diet and Cardiovascular Diseases. Cardiovasc Toxicol 2021;21:593-604. [PMID: 34003426 DOI: 10.1007/s12012-021-09656-z] [Reference Citation Analysis]
56 Fedotcheva N, Olenin A, Beloborodova N. Influence of Microbial Metabolites on the Nonspecific Permeability of Mitochondrial Membranes under Conditions of Acidosis and Loading with Calcium and Iron Ions. Biomedicines 2021;9:558. [PMID: 34067718 DOI: 10.3390/biomedicines9050558] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
57 Hoseini-Tavassol Z, Hasani-Ranjbar S. Targeting TMAO and its metabolic pathway for cardiovascular diseases treatment. J Diabetes Metab Disord 2021;20:1095-7. [PMID: 34178875 DOI: 10.1007/s40200-021-00819-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Flores-Guerrero JL, Post A, van Dijk PR, Connelly MA, Garcia E, Navis G, Bakker SJL, Dullaart RPF. Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease. Liver Int 2021. [PMID: 33993608 DOI: 10.1111/liv.14963] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Sikora M, Kiss N, Stec A, Giebultowicz J, Samborowska E, Jazwiec R, Dadlez M, Olszewska M, Rudnicka L. Trimethylamine N-Oxide, a Gut Microbiota-Derived Metabolite, Is Associated with Cardiovascular Risk in Psoriasis: A Cross-Sectional Pilot Study. Dermatol Ther (Heidelb) 2021;11:1277-89. [PMID: 33983475 DOI: 10.1007/s13555-021-00547-3] [Reference Citation Analysis]
60 Gao X, Sun G, Randell E, Tian Y, Zhou H. Systematic investigation of the relationships of trimethylamine N-oxide and L-carnitine with obesity in both humans and rodents. Food Funct 2020;11:7707-16. [PMID: 32915186 DOI: 10.1039/d0fo01743d] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 8.0] [Reference Citation Analysis]
61 Bergström H, Ekström L, Warnqvist A, Bergman P, Björkhem-Bergman L. Variations in biomarkers of dyslipidemia and dysbiosis during the menstrual cycle: a pilot study in healthy volunteers. BMC Womens Health 2021;21:166. [PMID: 33879161 DOI: 10.1186/s12905-021-01306-4] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
62 Andreotti F, Iervolino A, Navarese EP, Maggioni AP, Crea F, Scambia G. Precision Phenomapping of Acute Coronary Syndromes to Improve Patient Outcomes. J Clin Med 2021;10:1755. [PMID: 33919478 DOI: 10.3390/jcm10081755] [Reference Citation Analysis]
63 Farmer N, Gutierrez-Huerta CA, Turner BS, Mitchell VM, Collins BS, Baumer Y, Wallen GR, Powell-Wiley TM. Neighborhood Environment Associates with Trimethylamine-N-Oxide (TMAO) as a Cardiovascular Risk Marker. Int J Environ Res Public Health 2021;18:4296. [PMID: 33919545 DOI: 10.3390/ijerph18084296] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
64 Fettig NM, Osborne LC. Direct and indirect effects of microbiota-derived metabolites on neuroinflammation in multiple sclerosis. Microbes Infect 2021;23:104814. [PMID: 33775860 DOI: 10.1016/j.micinf.2021.104814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
65 Nogal A, Valdes AM, Menni C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes 2021;13:1-24. [PMID: 33764858 DOI: 10.1080/19490976.2021.1897212] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 31.0] [Reference Citation Analysis]
66 Wang D, Shi C, Ge ZH, Wei YX, Liu TT, Wang Y, Zhou XF, Yang ZJ, Wang WT, Zhang YW, Zhu XH, Zhang J, Li Y, Gong M, Wu XH, Duan HQ. Study of the Mechanism of Action of Guanxin Shutong Capsules in the Treatment of Coronary Heart Disease Based on Metabolomics. Front Pharmacol 2021;12:650438. [PMID: 33867992 DOI: 10.3389/fphar.2021.650438] [Reference Citation Analysis]
67 Gutiérrez-Cuevas J, Sandoval-Rodriguez A, Meza-Rios A, Monroy-Ramírez HC, Galicia-Moreno M, García-Bañuelos J, Santos A, Armendariz-Borunda J. Molecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge. Cells 2021;10:629. [PMID: 33809061 DOI: 10.3390/cells10030629] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
68 Zhang WQ, Wang YJ, Zhang A, Ding YJ, Zhang XN, Jia QJ, Zhu YP, Li YY, Lv SC, Zhang JP. TMA/TMAO in Hypertension: Novel Horizons and Potential Therapies. J Cardiovasc Transl Res 2021. [PMID: 33709384 DOI: 10.1007/s12265-021-10115-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Sugano M, Matsuoka R. Nutritional Viewpoints on Eggs and Cholesterol. Foods 2021;10:494. [PMID: 33669005 DOI: 10.3390/foods10030494] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
70 Adel FW, Chen HH. Trimethylamine-N-Oxide: The Link Between Loop Diuretics and Cardiovascular Outcomes? JACC Basic Transl Sci 2021;6:116-8. [PMID: 33688860 DOI: 10.1016/j.jacbts.2020.12.013] [Reference Citation Analysis]
71 Zhao X, Chen Y, Li L, Zhai J, Yu B, Wang H, Yang D, Wang Q, Chang Y, Li J, Zhang P, Zhang H, Li Y. Effect of DLT-SML on Chronic Stable Angina Through Ameliorating Inflammation, Correcting Dyslipidemia, and Regulating Gut Microbiota. J Cardiovasc Pharmacol 2021;77:458-69. [PMID: 33657052 DOI: 10.1097/FJC.0000000000000970] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Nabil A, Elshemy MM, Uto K, Soliman R, Hassan AA, Shiha G, Ebara M. Coronavirus (SARS-CoV-2) in gastroenterology and its current epidemiological situation: An updated review until January 2021. EXCLI J 2021;20:366-85. [PMID: 33746667 DOI: 10.17179/excli2021-3417] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Lim YJ, Sidor NA, Tonial NC, Che A, Urquhart BL. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets. Toxins (Basel) 2021;13:142. [PMID: 33668632 DOI: 10.3390/toxins13020142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
74 Buford TW. The Gut Microbiome and Aging. J Gerontol A Biol Sci Med Sci 2020;75:1229-31. [PMID: 32556115 DOI: 10.1093/gerona/glaa103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
75 Summers S, Quimby J, Yao L, Hess A, Broeckling C, Lappin M. Biological variation of major gut-derived uremic toxins in the serum of healthy adult cats. J Vet Intern Med 2021;35:902-11. [PMID: 33537991 DOI: 10.1111/jvim.16043] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Sikora M, Stec A, Chrabaszcz M, Giebultowicz J, Samborowska E, Jazwiec R, Dadlez M, Olszewska M, Rudnicka L. Clinical Implications of Intestinal Barrier Damage in Psoriasis. J Inflamm Res 2021;14:237-43. [PMID: 33542642 DOI: 10.2147/JIR.S292544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Xu HM, Huang HL, Zhou YL, Zhao HL, Xu J, Shou DW, Liu YD, Zhou YJ, Nie YQ. Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain. Gastroenterol Res Pract 2021;2021:6699268. [PMID: 33510784 DOI: 10.1155/2021/6699268] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
78 Gizard F, Fernandez A, De Vadder F. Interactions between gut microbiota and skeletal muscle. Nutr Metab Insights 2020;13:1178638820980490. [PMID: 33402830 DOI: 10.1177/1178638820980490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
79 Wu CL, Tarng DC. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease. Toxins (Basel) 2020;12:808. [PMID: 33419312 DOI: 10.3390/toxins12120808] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
80 Sharpton SR, Schnabl B, Knight R, Loomba R. Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease. Cell Metab 2021;33:21-32. [PMID: 33296678 DOI: 10.1016/j.cmet.2020.11.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
81 Zhao X, Oduro PK, Tong W, Wang Y, Gao X, Wang Q. Therapeutic potential of natural products against atherosclerosis: Targeting on gut microbiota. Pharmacol Res 2021;163:105362. [PMID: 33285231 DOI: 10.1016/j.phrs.2020.105362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
82 Koszewicz M, Jaroch J, Brzecka A, Ejma M, Budrewicz S, Mikhaleva LM, Muresanu C, Schield P, Somasundaram SG, Kirkland CE, Avila-Rodriguez M, Aliev G. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment. Pharmacol Res 2021;164:105277. [PMID: 33166735 DOI: 10.1016/j.phrs.2020.105277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
83 Zhang Y, Gu Y, Chen Y, Huang Z, Li M, Jiang W, Chen J, Rao W, Luo S, Chen Y, Chen J, Li L, Jia Y, Liu M, Zhou F. Dingxin Recipe IV attenuates atherosclerosis by regulating lipid metabolism through LXR-α/SREBP1 pathway and modulating the gut microbiota in ApoE-/- mice fed with HFD. J Ethnopharmacol 2021;266:113436. [PMID: 33011372 DOI: 10.1016/j.jep.2020.113436] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
84 Gerdes V, Gueimonde M, Pajunen L, Nieuwdorp M, Laitinen K. How strong is the evidence that gut microbiota composition can be influenced by lifestyle interventions in a cardio-protective way? Atherosclerosis 2020;311:124-42. [PMID: 32981713 DOI: 10.1016/j.atherosclerosis.2020.08.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
85 Matsumoto T, Kojima M, Takayanagi K, Taguchi K, Kobayashi T. Role of S-Equol, Indoxyl Sulfate, and Trimethylamine N-Oxide on Vascular Function. Am J Hypertens 2020;33:793-803. [PMID: 32300778 DOI: 10.1093/ajh/hpaa053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
86 Scarmozzino F, Poli A, Visioli F. Microbiota and cardiovascular disease risk: A scoping review. Pharmacological Research 2020;159:104952. [DOI: 10.1016/j.phrs.2020.104952] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
87 Guo F, Qiu X, Tan Z, Li Z, Ouyang D. Plasma trimethylamine n-oxide is associated with renal function in patients with heart failure with preserved ejection fraction. BMC Cardiovasc Disord 2020;20:394. [PMID: 32859154 DOI: 10.1186/s12872-020-01669-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
88 Israr MZ, Salzano A, Suzuki T. Gut Feeling: The Role of Gut Microbiota in Immunomodulation of Ischemia-Reperfusion Injury. Arterioscler Thromb Vasc Biol 2020;40:1967-9. [PMID: 32845773 DOI: 10.1161/ATVBAHA.120.314941] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
89 Simó C, García-Cañas V. Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development. Food Funct 2020;11:6745-76. [PMID: 32686802 DOI: 10.1039/d0fo01237h] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
90 Liang X, Zhang Z, Lv Y, Tong L, Liu T, Yi H, Zhou X, Yu Z, Tian X, Cui Q, Yang J, Gong P, Zhang L. Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis. Nutrition 2020;79-80:110941. [PMID: 32858376 DOI: 10.1016/j.nut.2020.110941] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
91 Diaz-Ricart M, Torramade-Moix S, Pascual G, Palomo M, Moreno-Castaño AB, Martinez-Sanchez J, Vera M, Cases A, Escolar G. Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease. Toxins (Basel) 2020;12:E361. [PMID: 32492843 DOI: 10.3390/toxins12060361] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
92 Battaglini D, Robba C, Lopes da Silva A, Dos Santos Samary C, Leme Silva P, Dal Pizzol F, Pelosi P, Rocco PRM. Brain-heart interaction after acute ischemic stroke. Crit Care 2020;24:163. [PMID: 32317013 DOI: 10.1186/s13054-020-02885-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
93 Villette R, Kc P, Beliard S, Salas Tapia MF, Rainteau D, Guerin M, Lesnik P. Unraveling Host-Gut Microbiota Dialogue and Its Impact on Cholesterol Levels. Front Pharmacol 2020;11:278. [PMID: 32308619 DOI: 10.3389/fphar.2020.00278] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
94 Vendrik KEW, Ooijevaar RE, de Jong PRC, Laman JD, van Oosten BW, van Hilten JJ, Ducarmon QR, Keller JJ, Kuijper EJ, Contarino MF. Fecal Microbiota Transplantation in Neurological Disorders. Front Cell Infect Microbiol 2020;10:98. [PMID: 32266160 DOI: 10.3389/fcimb.2020.00098] [Cited by in Crossref: 47] [Cited by in F6Publishing: 95] [Article Influence: 23.5] [Reference Citation Analysis]
95 Sanchez-Rodriguez E, Egea-Zorrilla A, Plaza-Díaz J, Aragón-Vela J, Muñoz-Quezada S, Tercedor-Sánchez L, Abadia-Molina F. The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases. Nutrients 2020;12:E605. [PMID: 32110880 DOI: 10.3390/nu12030605] [Cited by in Crossref: 33] [Cited by in F6Publishing: 50] [Article Influence: 16.5] [Reference Citation Analysis]
96 Liu Y, Dai M. Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis. Mediators Inflamm 2020;2020:4634172. [PMID: 32148438 DOI: 10.1155/2020/4634172] [Cited by in Crossref: 14] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]